MDXH Stock — Price, Charts & Analysis

MDxHealth SA (MDXH) has no trailing P/E shown and a forward P/E of -1.89x. This places MDXH in not enough valuation data territory based on the valuation data currently available on Worldtickers.

MDXH trades with -1.89x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MDXH looks overvalued or undervalued.

MDXH's P/E of -1.89x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MDXH's trailing EPS is -$0.71 and forward EPS is -$0.38.

EPS, or earnings per share, shows how much profit MDxHealth SA generated for each share. MDXH's trailing EPS is -$0.71, and investors usually prefer EPS that is positive and growing over time.

MDxHealth SA has a market cap of $68.70M, making MDXH a small-cap stock based on the current market value shown on Worldtickers.

MDXH's latest stock price on Worldtickers is $0.72. The latest move is -$0.04 or -5.15%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MDXH's quote includes a latest price of $0.72. The market open is $0.78. Previous close is $0.76. The intraday range is $0.72 to $0.79.

MDXH is down in the latest quote, with a move of -$0.04 or -5.15%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MDXH generated $114.02M in trailing revenue. Revenue growth is 2.30%, which helps show whether demand is expanding or slowing.

MDXH's revenue growth is 2.30%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, MDXH does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$36.43M.

Gross margin is 62.86%. Margins show how efficiently MDxHealth SA turns revenue into profit.

MDxHealth SA carries $105.85M and holds $19.21M in cash.

MDXH holds $19.21M on its balance sheet.

MDXH's book value per share is -$0.58.

Institutions hold 45.19% of MDXH shares. Insiders hold 22.14% of shares. Ownership mix helps investors understand how much of MDxHealth SA is held by professional investors and company insiders.

MDXH has 95.42M shares outstanding. Float shares are 39.96M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MDXH, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MDXH is -$0.38. Revenue growth is 2.30%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MDXH's trailing EPS is -$0.71. Forward EPS is -$0.38. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MDXH is in the Healthcare sector. Its earnings multiple is -1.89x. Its latest displayed growth metric is 2.30%. Compare these figures with sector peers before deciding whether MDxHealth SA is stronger or weaker than average.

MDXH trades at $0.72. The stock trades at -1.89x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of MDxHealth SA's fundamentals.

MDXH risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -501,440.84, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MDXH should be compared with companies in Diagnostics & Research. Its earnings multiple is -1.89x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

MDxHealth SA (MDXH) operates in Healthcare, specifically Diagnostics & Research. MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized

MDXH trades on NasdaqCM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MDXH stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

MDxHealth SA's official website listed on Worldtickers is mdxhealth.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

MDxHealth SA employs about 364 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

MDxHealth SA is headquartered in Herstal, Belgium. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MDXH is in the Healthcare sector and the Diagnostics & Research industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MDXH has traded between $0.40 and $5.33 over the past 52 weeks. At $0.72, it is 86.49% below the high and 80.00% above the low. The 52-week range helps gauge long-term price momentum.

MDXH is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is $0.50 and its 200-day moving average is $2.31.

MDXH's RSI is 64.29. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MDXH's latest RSI reading is 64.29, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MDXH is near $0.40. Key resistance is near $1.13. Breaks above resistance or below support can change the short-term technical setup.

MDXH's nearest reported support level is $0.40. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MDXH's nearest reported resistance level is $1.13. A breakout above resistance can improve momentum, especially when volume confirms the move.

MDXH trades about 6.18M shares daily on average. The latest displayed volume is 544.66K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MDXH's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MDXH is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 64.29 (neutral). MACD is bullish. Nearest support is around $0.40. Resistance is around $1.13. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $0.52 (38.50% from price). MA50 is $0.50 (45.03% from price). MA200 is $2.31 (-68.86% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MDXH's MA20 is $0.52. MA50 is $0.50. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MDXH's pivot is near $0.78. Support is near $0.40. Resistance is near $1.13. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for MDXH is near $0.55. The next upper resistance zone is near $1.96. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MDXH's Bollinger range is roughly $0.21 to $0.83. Band width is near 117.43%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MDXH's ATR-based typical daily range is about 12.91%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 544.66K shares. Average volume is about 6.18M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MDXH's all-time high shown on Worldtickers is $13.17. Its all-time low is $0.35. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MDXH has a beta of -501,440.84, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.